Masahiro Serikawa

1.3k total citations
61 papers, 620 citations indexed

About

Masahiro Serikawa is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Masahiro Serikawa has authored 61 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Surgery, 42 papers in Oncology and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Masahiro Serikawa's work include Pancreatic and Hepatic Oncology Research (33 papers), Gallbladder and Bile Duct Disorders (23 papers) and Pancreatitis Pathology and Treatment (19 papers). Masahiro Serikawa is often cited by papers focused on Pancreatic and Hepatic Oncology Research (33 papers), Gallbladder and Bile Duct Disorders (23 papers) and Pancreatitis Pathology and Treatment (19 papers). Masahiro Serikawa collaborates with scholars based in Japan, Greece and United Kingdom. Masahiro Serikawa's co-authors include Tamito Sasaki, Kazuaki Chayama, Yasutaka Ishii, Yoshifumi Fujimoto, T. Tsuboi, Keiji Hanada, Takashi Ishigaki, Tomoyuki Minami, Masafumi Nakamura and Tooru Shimosegawa and has published in prestigious journals such as PLoS ONE, British Journal of Haematology and Annals of Surgical Oncology.

In The Last Decade

Masahiro Serikawa

54 papers receiving 608 citations

Peers

Masahiro Serikawa
Muti Abulafi United Kingdom
H. Bill Xie United States
Y-K. Kang South Korea
Jun Chul Chung South Korea
Gözde Kır Türkiye
Masahiro Serikawa
Citations per year, relative to Masahiro Serikawa Masahiro Serikawa (= 1×) peers Zhendong Jin

Countries citing papers authored by Masahiro Serikawa

Since Specialization
Citations

This map shows the geographic impact of Masahiro Serikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Serikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Serikawa more than expected).

Fields of papers citing papers by Masahiro Serikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Serikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Serikawa. The network helps show where Masahiro Serikawa may publish in the future.

Co-authorship network of co-authors of Masahiro Serikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Serikawa. A scholar is included among the top collaborators of Masahiro Serikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Serikawa. Masahiro Serikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sumiyoshi, Tatsuaki, Kenichiro Uemura, Kenjiro Okada, et al.. (2024). Clinical Utility of the Combined Use of CA19-9 and DUPAN-2 in Pancreatic Adenocarcinoma. Annals of Surgical Oncology. 31(7). 4665–4672. 7 indexed citations
2.
Uemura, Kenichiro, Tatsuaki Sumiyoshi, Kenjiro Okada, et al.. (2023). Optimal Lymphadenectomy in Patients with Well-Differentiated Nonfunctioning Pancreatic Neuroendocrine Neoplasms. Journal of Clinical Medicine. 12(21). 6778–6778. 1 indexed citations
3.
Ohtsuka, Takao, Masafumi Nakamura, Susumu Hijioka, et al.. (2023). Feasibility of Surveillance for Mucinous Cystic Neoplasm of the Pancreas. Pancreas. 52(5). e288–e292. 2 indexed citations
4.
5.
Ishii, Yasutaka, Masahiro Serikawa, Wataru Okamoto, et al.. (2023). A case of unresectable intrahepatic cholangiocarcinoma with a germline BRCA1 mutation. Clinical Journal of Gastroenterology. 16(3). 470–475.
6.
Sumiyoshi, Tatsuaki, Kenichiro Uemura, Taiichi Takasaki, et al.. (2023). Hepatic artery resection in distal cholangiocarcinoma. Langenbeck s Archives of Surgery. 408(1). 58–58. 1 indexed citations
7.
Sumiyoshi, Tatsuaki, Kenichiro Uemura, Kenjiro Okada, et al.. (2023). Prognostic impact of lung recurrence in patients with biliary tract cancer. Langenbeck s Archives of Surgery. 408(1). 290–290.
8.
Ishikawa, Akira, Hiroki Fujii, Kazuhiro Sentani, et al.. (2022). Expression of kinesin family member C1 in pancreatic ductal adenocarcinoma affects tumor progression and stemness. Pathology - Research and Practice. 241. 154277–154277. 8 indexed citations
9.
Sumiyoshi, Tatsuaki, Kenichiro Uemura, Kenjiro Okada, et al.. (2022). A case of unresectable locally advanced intrahepatic cholangiocarcinoma that achieved pathological complete response after gemcitabine and S1 chemotherapy. Clinical Journal of Gastroenterology. 15(6). 1164–1168. 1 indexed citations
11.
Okada, Kenjiro, Kenichiro Uemura, Naru Kondo, et al.. (2021). Neoadjuvant therapy contributes to nodal downstaging of pancreatic cancer. Langenbeck s Archives of Surgery. 407(2). 623–632. 4 indexed citations
12.
Okada, Kenjiro, Kenichiro Uemura, Naru Kondo, et al.. (2021). Preoperative risk factors for para-aortic lymph node positivity in pancreatic cancer. Pancreatology. 21(3). 606–612. 7 indexed citations
13.
Fujino, Hatsue, Daiki Miki, Yasutaka Ishii, et al.. (2020). Clinical Usefulness of Serum Autotaxin for Early Prediction of Relapse in Male Patients with Type 1 Autoimmune Pancreatitis. Digestive Diseases and Sciences. 66(4). 1268–1275. 5 indexed citations
14.
Ishii, Yasutaka, Masahiro Serikawa, T. Tsuboi, et al.. (2020). Usefulness of peroral cholangioscopy in the differential diagnosis of IgG4-related sclerosing cholangitis and extrahepatic cholangiocarcinoma: a single-center retrospective study. BMC Gastroenterology. 20(1). 287–287. 8 indexed citations
15.
Tsuboi, T., Masahiro Serikawa, Tamito Sasaki, et al.. (2017). Use of 4-Fr versus 6-Fr Nasobiliary Catheter for Biliary Drainage: A Prospective, Multicenter, Randomized, Controlled Study. Diagnostic and therapeutic endoscopy. 2017. 1–7. 2 indexed citations
16.
Kanno, Atsushi, Atsushi Masamune, Keiji Hanada, et al.. (2017). Multicenter study of early pancreatic cancer in Japan. Pancreatology. 18(1). 61–67. 168 indexed citations
17.
Yamamoto, Hideya, Eiji Sugiyama, Masahiro Serikawa, et al.. (2017). Clinical features and predictive value of serum inflammatory markers of perivascular involvement in immunoglobulin G4-related disease. Heart and Vessels. 32(10). 1176–1185. 6 indexed citations
18.
Sasaki, Tamito, Masahiro Serikawa, Tomoyuki Minami, et al.. (2014). A case of microgastrinoma diagnosed by selective arterial calcium injection test. Suizo. 29(1). 74–82.
19.
Sakai, Akira, Yoshiaki Kuroda, Yuta Katayama, et al.. (2007). Connective tissue growth factor is an indicator of bone involvement in multiple myeloma, but matrix metalloproteinase‐9 is not. British Journal of Haematology. 139(1). 41–50. 14 indexed citations
20.
Serikawa, Masahiro, et al.. (2006). Management of Intraductal Papillary-mucinous Neoplasm of the Pancreas. Journal of Clinical Gastroenterology. 40(9). 856–862. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026